Premier Biomedical Statistics
Premier Biomedical (BIEI) Stock Statistics & Valuation Metrics
Total Valuation
Premier Biomedical has a market cap or net worth of $1.18M. The enterprise value is $1.85T.
- Market Cap
- $1.18M
- Enterprise Value
- $1.85T
Share Statistics
Premier Biomedical has 1,689,881,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,689,881,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Premier Biomedical’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 8.94%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- -27.49
- Return on Invested Capital (ROIC)
- 8.94%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 0
- Profits Per Employee
- -50.50K
- Employee Count
- 4
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Premier Biomedical is -25.15. Premier Biomedical’s PEG ratio is -0.25.
- PE Ratio
- -25.15
- PS Ratio
- 22.64
- PB Ratio
- -0.51
- Price to FCF
- -67.69
- Price to Operating Cash Flow
- -67.68
- PEG Ratio
- -0.25
Income Statement
In the last 12 months, Premier Biomedical had revenue of 0 and earned -202.00K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -171.00K
- Pretax Income
- -202.00K
- Net Income
- -202.00K
- EBITDA
- -3,105
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -19.50K and capital expenditures 0, giving a free cash flow of -19.50K billion.
- Operating Cash Flow
- -19.50K
- Free Cash Flow
- -19.50K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Premier Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.48%
- Earnings Yield
- -3.98%
Stock Price Statistics
- Beta
- -0.09
- 52-Week Price Change
- -94.90%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Premier Biomedical as a current ratio of 0.00, with Debt / Equity ratio of -22.90%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.57
- Net Debt to EBITDA
- -181.68
- Interest Coverage Ratio
- -5.52
Taxes
In the past 12 months, Premier Biomedical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Premier Biomedical EV to EBITDA ratio is -39.25, with an EV/FCF ratio of -105.63.
- EV to Sales
- 35.33
- EV to EBITDA
- -39.25
- EV to Free Cash Flow
- -105.63
- EV to Operating Cash Flow
- -105.62
Balance Sheet
Premier Biomedical has $400.00 in cash and marketable securities with $720.19K in debt, giving a net cash position of -$719.79K billion.
- Cash & Marketable Securities
- $400.00
- Total Debt
- $720.19K
- Net Cash
- -$719.79K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 56.60%, with operating margin of -90.00%, and net profit margin of -90.00%.
- Gross Margin
- 56.60%
- Operating Margin
- -90.00%
- Pretax Margin
- -90.00%
- Net Profit Margin
- -90.00%
- EBITDA Margin
- -90.00%
- EBIT Margin
- -90.00%
